Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current treatment of non-alcoholic fatty liver disease.
Paternostro R, Trauner M. Paternostro R, et al. J Intern Med. 2022 Aug;292(2):190-204. doi: 10.1111/joim.13531. Epub 2022 Jul 7. J Intern Med. 2022. PMID: 35796150 Free PMC article. Review.
Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine.
Bota S, Paternostro R, Etschmaier A, Schwarzer R, Salzl P, Mandorfer M, Kienbacher C, Ferlitsch M, Reiberger T, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Bota S, et al. Among authors: paternostro r. Ultrasound Med Biol. 2015 Sep;41(9):2340-9. doi: 10.1016/j.ultrasmedbio.2015.04.013. Epub 2015 May 23. Ultrasound Med Biol. 2015. PMID: 26004669
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy.
Rutter K, Etschmaier A, Ferlitsch M, Maieron A, Hametner S, Horvatits T, Paternostro R, Salzl P, Reiberger T, Peck-Radosavljevic M, Quehenberger P, Hofer H, Trauner M, Ferenci P, Ferlitsch A. Rutter K, et al. Among authors: paternostro r. Dig Liver Dis. 2016 Oct;48(10):1194-9. doi: 10.1016/j.dld.2016.06.033. Epub 2016 Jul 19. Dig Liver Dis. 2016. PMID: 27476467
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.
Schwarzer R, Kivaranovic D, Mandorfer M, Paternostro R, Wolrab D, Heinisch B, Reiberger T, Ferlitsch M, Gerner C, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Schwarzer R, et al. Among authors: paternostro r. Aliment Pharmacol Ther. 2018 Jan;47(1):86-94. doi: 10.1111/apt.14377. Epub 2017 Nov 3. Aliment Pharmacol Ther. 2018. PMID: 29105115 Clinical Trial.
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, Ay C, Quehenberger P, Fritzer-Szekeres M, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferlitsch A; Vienna Hepatic Hemodynamic Lab. Mandorfer M, et al. Among authors: paternostro r. Aliment Pharmacol Ther. 2018 Apr;47(7):980-988. doi: 10.1111/apt.14522. Epub 2018 Jan 29. Aliment Pharmacol Ther. 2018. PMID: 29377193
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
Mandorfer M, Scheiner B, Stättermayer AF, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P, Ferlitsch A. Mandorfer M, et al. Among authors: paternostro r. Aliment Pharmacol Ther. 2018 Aug;48(4):451-459. doi: 10.1111/apt.14856. Epub 2018 Jun 29. Aliment Pharmacol Ther. 2018. PMID: 29956823 Free PMC article.
71 results